Study of Smith-Lemli-Opitz Syndrome
NCT00001721
·
clinicaltrials.gov ↗
COMPLETED
Status
130
Enrollment
NIH
Sponsor class
Conditions
Smith-Lemli-Opitz Syndrome
Interventions
DRUG:
Cholesterol Suspension
DRUG:
CRH
DRUG:
Cholesterol
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)